Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Firmagon in Indian patients with advanced prostate cancer
NCT02726009Phase 4Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- May 2016
- Primary completion
- May 2020
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of degarelix in prostate cancer (PCa), sponsored by Ferring Pharmaceuticals. Started May 2016; status: completed.
02
Drugs
degarelix
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02726009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02726009.